ChemicalBook
English   Japanese   Germany   Korea

(+)-L-Arg-[(4S)-4-Hydroxy-L-Arg-]-D-Orn-L-Thr-D-Orn-[(4S)-4-hydroxy-L-Arg-]-D-Tyr-OH

, 74899-63-1, 结构式
CAS号:
74899-63-1
英文名:
(+)-L-Arg-[(4S)-4-Hydroxy-L-Arg-]-D-Orn-L-Thr-D-Orn-[(4S)-4-hydroxy-L-Arg-]-D-Tyr-OH
英文别名:
K-582B;(+)-Myroridin KB;Antibiotic K-582B;Myroridin KB (9CI);(+)-6-(threo-4-Hydroxy-L-Arg)myroridin KA;(+)-L-Arg-[(4S)-4-Hydroxy-L-Arg-]-D-Orn-L-Thr-D-Orn-[(4S)-4-hydroxy-L-Arg-]-D-Tyr-OH;(2R)-2-[[(2S)-2-[[(2R)-5-amino-2-[[(2S,3R)-2-[[(2R)-5-amino-2-[[(2S,4S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)-4-hydroxypentanoyl]amino]pentanoyl]amino]-3-hydroxybutanoyl]amino]pentanoyl]amino]-5-(diaminomethylideneamino)-4-hydroxypentanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid
中文名:
中文别名:
CBNumber:
CB72236811
分子式:
C41H74N18O12
分子量:
1011.16
MOL File:
74899-63-1.mol

(+)-L-Arg-[(4S)-4-Hydroxy-L-Arg-]-D-Orn-L-Thr-D-Orn-[(4S)-4-hydroxy-L-Arg-]-D-Tyr-OH化学性质

密度:
1.57±0.1 g/cm3(Predicted)
酸度系数(pKa):
3.07±0.10(Predicted)
安全信息

(+)-L-Arg-[(4S)-4-Hydroxy-L-Arg-]-D-Orn-L-Thr-D-Orn-[(4S)-4-hydroxy-L-Arg-]-D-Tyr-OH性质、用途与生产工艺

(+)-L-Arg-[(4S)-4-Hydroxy-L-Arg-]-D-Orn-L-Thr-D-Orn-[(4S)-4-hydroxy-L-Arg-]-D-Tyr-OH 上下游产品信息

上游原料

下游产品


(+)-L-Arg-[(4S)-4-Hydroxy-L-Arg-]-D-Orn-L-Thr-D-Orn-[(4S)-4-hydroxy-L-Arg-]-D-Tyr-OH 生产厂家

 

74899-63-1, (+)-L-Arg-[(4S)-4-Hydroxy-L-Arg-]-D-Orn-L-Thr-D-Orn-[(4S)-4-hydroxy-L-Arg-]-D-Tyr-OH 相关搜索:

  • C41H74N18O12
  • 74899-63-1
  • Myroridin KB (9CI)
  • (2R)-2-[[(2S)-2-[[(2R)-5-amino-2-[[(2S,3R)-2-[[(2R)-5-amino-2-[[(2S,4S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)-4-hydroxypentanoyl]amino]pentanoyl]amino]-3-hydroxybutanoyl]amino]pentanoyl]amino]-5-(diaminomethylideneamino)-4-hydroxypentanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid
  • Antibiotic K-582B
  • (+)-Myroridin KB
  • (+)-L-Arg-[(4S)-4-Hydroxy-L-Arg-]-D-Orn-L-Thr-D-Orn-[(4S)-4-hydroxy-L-Arg-]-D-Tyr-OH
  • (+)-6-(threo-4-Hydroxy-L-Arg)myroridin KA
  • K-582B
Copyright 2016 © ChemicalBook. All rights reserved